Pfizer
Patents, Design & Utilities
Last updated:
List of all Pfizer patents 451 in total
| Status | Patent |
|---|---|
Grant | Utility: 6,7,8,9-tetrahydro-5H-pyrido[2,3-d]azepine dopamine D3 ligands Filling date: 13 Sep 2025 Issue date: 19 Jul 2022 |
Application | Utility: DOSING REGIMEN OF AVELUMAB FOR THE TREATMENT OF CANCER Filling date: 13 Sep 2025 Issue date: 14 Jul 2022 |
Application | Utility: METABOLITES OF GLP1R AGONISTS Filling date: 13 Sep 2025 Issue date: 7 Jul 2022 |
Grant | Utility: Antibodies specific for CD70 and their uses Filling date: 13 Sep 2025 Issue date: 5 Jul 2022 |
Application | Utility: REAL-TIME TRACKING AND MANAGEMENT OF STANDARD WORKFLOWS Filling date: 13 Sep 2025 Issue date: 30 Jun 2022 |
Application | Utility: METABOLITES OF GLP1R AGONISTS Filling date: 13 Sep 2025 Issue date: 23 Jun 2022 |
Grant | Utility: Bifunctional cytotoxic agents containing the CTI pharmacophore Filling date: 13 Sep 2025 Issue date: 21 Jun 2022 |
Grant | Utility: Cysteine engineered antibody drug conjugates Filling date: 13 Sep 2025 Issue date: 21 Jun 2022 |
Grant | Utility: Anti-ROBO2 antibodies, compositions, methods and uses thereof Filling date: 13 Sep 2025 Issue date: 21 Jun 2022 |
Application | Utility: (AZA)Benzothiazolyl Substituted Pyrazole Compounds Filling date: 13 Sep 2025 Issue date: 16 Jun 2022 |
Application | Utility: IMMUNOGENIC COMPOSITIONS COMPRISING CONJUGATED CAPSULAR SACCHARIDE ANTIGENS, KITS COMPRISING THE SAME AND USES THEREOF Filling date: 13 Sep 2025 Issue date: 16 Jun 2022 |
Grant | Utility: Anti-AVB8 antibodies and compositions and uses thereof Filling date: 13 Sep 2025 Issue date: 14 Jun 2022 |
Application | Utility: STABLE LIQUID ANTIBODY FORMULATION Filling date: 13 Sep 2025 Issue date: 9 Jun 2022 |
Grant | Utility: Nitrile-containing antiviral compounds Filling date: 13 Sep 2025 Issue date: 7 Jun 2022 |
Application | Utility: ESCHERICHIA COLI COMPOSITIONS AND METHODS THEREOF Filling date: 13 Sep 2025 Issue date: 2 Jun 2022 |
Application | Utility: TIME TO RESOLUTION OF AXITINIB-RELATED ADVERSE EVENTS Filling date: 13 Sep 2025 Issue date: 2 Jun 2022 |
Application | Utility: COMPOSITIONS AND METHODS FOR ELICITING AN IMMUNE RESPONSE AGAINST CLOSTRIDIUM DIFFICILE Filling date: 13 Sep 2025 Issue date: 26 May 2022 |
Grant | Utility: Toll-like receptor agonists Filling date: 13 Sep 2025 Issue date: 24 May 2022 |
Application | Utility: ESCHERICHIA COLI COMPOSITIONS AND METHODS THEREOF Filling date: 13 Sep 2025 Issue date: 19 May 2022 |
Application | Utility: TOFACITINIB ORAL SUSTAINED RELEASE DOSAGE FORMS Filling date: 13 Sep 2025 Issue date: 12 May 2022 |
Application | Utility: Nitrile-Containing Antiviral Compounds Filling date: 13 Sep 2025 Issue date: 12 May 2022 |
Application | Utility: CRYSTALLINE PYRIMIDINYL-3,8-DIAZABICYCLO[3.2.1]OCTANYLMETHANONE COMPOUND AND USE THEREOF Filling date: 13 Sep 2025 Issue date: 12 May 2022 |
Grant | Utility: Crystalline 2-amino-2-(hydroxymethyl)propane-1,3-diol salt of 4-(4-(1-isopropyl-7-OXO-1,4,6,7-tetrahydrospiro[indazole-5,4'-piperidine]- -1'-carbonyl)-6-methoxypryridin-2-YL)benzoic acid Filling date: 13 Sep 2025 Issue date: 10 May 2022 |
Grant | Utility: Site-specific integration Filling date: 13 Sep 2025 Issue date: 10 May 2022 |
Application | Utility: Methods for purifying bacterial polysaccharides Filling date: 13 Sep 2025 Issue date: 5 May 2022 |
Application | Utility: Method of treatment of Chronic Low Back Pain Filling date: 13 Sep 2025 Issue date: 5 May 2022 |
Application | Utility: MANUFACTURING PROCESS AND INTERMEDIATES FOR A PYRROLO[2,3-D]PYRIMIDINE COMPOUND AND USE THEREOF Filling date: 13 Sep 2025 Issue date: 28 Apr 2022 |
Application | Utility: COMBINATION OF A CDK INHIBITOR AND A PIM INHIBITOR Filling date: 13 Sep 2025 Issue date: 28 Apr 2022 |
Application | Utility: CRYSTALLINE FORM OF A CDK INHIBITOR Filling date: 13 Sep 2025 Issue date: 28 Apr 2022 |
Grant | Utility: Chimeric antigen receptors targeting B-cell maturation antigen Filling date: 13 Sep 2025 Issue date: 26 Apr 2022 |
Grant | Utility: Imidazo[4,5-C]quinoline derivatives as LRRK2 inhibitors Filling date: 13 Sep 2025 Issue date: 26 Apr 2022 |
Application | Utility: Antibodies to MAdCAM Filling date: 13 Sep 2025 Issue date: 21 Apr 2022 |
Application | Utility: NEISSERIA MENINGITIDIS COMPOSITIONS AND METHODS THEREOF Filling date: 13 Sep 2025 Issue date: 21 Apr 2022 |
Application | Utility: CDCP1-TARGETED THERAPIES Filling date: 13 Sep 2025 Issue date: 21 Apr 2022 |
Application | Utility: CD1a ANTIBODIES AND USES THEREOF Filling date: 13 Sep 2025 Issue date: 14 Apr 2022 |
Grant | Utility: Crystalline form of lorlatinib free base hydrate Filling date: 13 Sep 2025 Issue date: 12 Apr 2022 |
Application | Utility: CYCLIN DEPENDENT KINASE INHIBITORS Filling date: 13 Sep 2025 Issue date: 24 Mar 2022 |
Application | Utility: NOVEL 3-AMINO-PYRROLO[3,4-C]PYRAZOLE-5(1H, 4H,6H) CARBALDEHYDE DERIVATIVES Filling date: 13 Sep 2025 Issue date: 24 Mar 2022 |
Application | Utility: HUMAN CYTOMEGALOVIRUS GB POLYPEPTIDE Filling date: 13 Sep 2025 Issue date: 24 Mar 2022 |
Grant | Utility: Antibodies specific for epidermal growth factor receptor variant III and their uses Filling date: 13 Sep 2025 Issue date: 22 Mar 2022 |
Grant | Utility: Dosing regimen of avelumab for the treatment of cancer Filling date: 13 Sep 2025 Issue date: 15 Mar 2022 |
Application | Utility: Pharmaceutical Compositions and Methods Comprising A Combination of a Benzoxazole Transthyretin Stabilizer and an Additional Therapeutic Agent Filling date: 13 Sep 2025 Issue date: 10 Mar 2022 |
Grant | Utility: Chimeric antigen receptors targeting epidermal growth factor receptor variant III Filling date: 13 Sep 2025 Issue date: 8 Mar 2022 |
Application | Utility: Nitrile-Containing Antiviral Compounds Filling date: 13 Sep 2025 Issue date: 3 Mar 2022 |
Grant | Utility: Escherichia coli compositions and methods thereof Filling date: 13 Sep 2025 Issue date: 1 Mar 2022 |
Grant | Utility: Manufacturing process and intermediates for a pyrrolo[2,3-d]pyrimidine compound and use thereof Filling date: 13 Sep 2025 Issue date: 22 Feb 2022 |
Grant | Utility: Tofacitinib oral sustained release dosage forms Filling date: 13 Sep 2025 Issue date: 22 Feb 2022 |
Grant | Utility: Combinations for treatment of NASH/NAFLD and related diseases Filling date: 13 Sep 2025 Issue date: 22 Feb 2022 |
Grant | Utility: Pyrazolo[1,5-A]pyrazin-4-yl and related derivatives Filling date: 13 Sep 2025 Issue date: 22 Feb 2022 |
Application | Utility: SSI CELLS WITH PREDICTABLE AND STABLE TRANSGENE EXPRESSION AND METHODS OF FORMATION Filling date: 13 Sep 2025 Issue date: 17 Feb 2022 |
Showing 1 to 50 of 451 patents.